Evidence map›Paper›PMID 30235349›Full record

ArticlePloS one2018

Temporal and molecular dynamics of human metastatic breast carcinoma cell adhesive interactions with human bone marrow endothelium analyzed by single-cell force spectroscopy.

Leike Xie, Zhe Sun, Zhongkui Hong, Nicola J Brown, Olga V Glinskii, Kate Rittenhouse-Olson, Gerald A Meininger, Vladislav V Glinsky

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Leike XieDalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri, United States of America.
Zhe SunDalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri, United States of America.
Zhongkui HongDalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri, United States of America.
Nicola J BrownMicrocirculation Research Group, Department of Oncology, School of Medicine, University of Sheffield, Sheffield, United Kingdom.
Olga V GlinskiiDepartment of Medical Pharmacology and Physiology, School of Medicine, University of Missouri, Columbia, Missouri, United States of America.
Kate Rittenhouse-OlsonDepartment of Biotechnical & Clinical Laboratory Sciences, University at Buffalo, Buffalo, New York, United States of America.
Gerald A MeiningerDalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri, United States of America.
Vladislav V GlinskyDepartment of Pathology and Anatomical Sciences, School of Medicine, University of Missouri, Columbia, Missouri, United States of America.ORCID 0000-0003-0893-4388
University of Missouri · USHarry S. Truman Memorial Veterans' Hospital · USFor Robin (United States) · USUniversity of Sheffield · GB

Funding

Regulation Microvascular: Smooth Muscle Contraction ECM-Integrin-CytoskeletalP01HL095486 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI DAVIS, GEORGE E · 2010 to 2014
$8.4M
Clinical Translation of an Anti-Metastatic Antibody for Breast Cancer TherapyR42CA176951 · NCI · FOR-ROBIN · PI RITTENHOUSE-OLSON, KATE W · 2015 to 2016
$2.0M
Intravascular Integrin - Mediated Steps in Breast Cancer MetastasisR01CA160461 · NCI · UNIVERSITY OF MISSOURI-COLUMBIA · PI GLINSKII, VLADISLAV V · 2013 to 2017
$1.4M
Clinical Translation of an Anti-Metastatic Antibody for Breast Cancer TherapyR41CA176951 · NCI · FOR-ROBIN · PI RITTENHOUSE-OLSON, KATE W · 2013 to 2014
$411k
BLRD VA I01 BX000609NCI NIH HHS R01 CA160461NCI NIH HHS R41 CA176951NCI NIH HHS R42 CA176951NHLBI NIH HHS P01 HL095486
6 · The paper itself

Abstract

Bone is a common site of metastasis for breast cancer and the mechanisms of metastasis are not fully elucidated. The purpose of our study was to characterize temporal and molecular dynamics of adhesive interactions between human breast cancer cells (HBCC) and human bone marrow endothelium (HBME) with piconewton resolution using atomic force microscopy (AFM). In adhesion experiments, a single breast cancer cell, MDA-MB-231 (MB231) or MDA-MB-435 (MB435) was attached to the AFM cantilever and brought into contact with a confluent HBME monolayer for different time periods (0.5 to 300 sec). The forces required to rupture individual molecular interactions and completely separate interacting cells were analyzed as measures of cell-cell adhesion. Adhesive interactions between HBME and either MB231 or MB435 cells increased progressively as cell-cell contact time was prolonged from 0.5 to 300 sec due to the time-dependent increase in the number and frequency of individual adhesive events, as well as to the involvement of stronger ligand-receptor interactions over time. Studies of the individual molecule involvement revealed that Thomsen-Friedenreich antigen (TF-Ag), galectin-3, integrin-β1, and integrin-α3 are all contributing to HBCC/HBME adhesion to various degrees in a temporally defined fashion. In conclusion, cell-cell contact time enhances adhesion of HBCC to HBME and the adhesion is mediated, in part, by TF-Ag, galectin-3, integrin-α3, and integrin-β1.

Indexed as

Cell AdhesionMicroscopy, Atomic ForceBone Marrow CellsBreast NeoplasmsCell Line, TumorEndotheliumHumansKineticsNeoplasm Metastasis

Identifiers

PMID30235349
PMCPMC6147572
OpenAlexW2889589644

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.